AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Vanhanen, M Kivipelto, M Koivisto, K Kuusisto, J Mykkanen, L Helkala, EL Hanninen, T Kervinen, K Kesaniemi, YA Laakso, MP Soininen, H Laakso, M
Citation: M. Vanhanen et al., APOE-epsilon 4 is associated with weight loss in women with AD - A population-based study, NEUROLOGY, 56(5), 2001, pp. 655-659

Authors: Koivisto, AM Lempiainen, P Koivisto, K Helkala, EL Mykkanen, L Kuusisto, J Kervinen, K Kesaniemi, YA Laakso, M Soininen, H
Citation: Am. Koivisto et al., Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: A population-based longitudinal study, NEUROEPIDEM, 19(6), 2000, pp. 327-332

Authors: Niemi, M Kervinen, K Kiviniemi, H Lukkarinen, O Kyllonen, AP Apaja-Sarkkinen, M Savolainen, MJ Kairaluoma, MI Kesaniemi, YA
Citation: M. Niemi et al., Apolipoprotein E phenotype, cholesterol and breast and prostate cancer, J EPIDEM C, 54(12), 2000, pp. 938-939

Authors: Paassilta, M Karjalainen, A Kervinen, K Savolainen, MJ Heikkinen, J Backstrom, AC Kesaniemi, YA
Citation: M. Paassilta et al., Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a)levels, ATHEROSCLER, 149(1), 2000, pp. 157-162

Authors: Gerdes, LU Gerdes, C Kervinen, K Savolainen, M Klausen, IC Hansen, PS Kesaniemi, YA Faergeman, O
Citation: Lu. Gerdes et al., The apolipoprotein epsilon 4 allele determines prognosis and the effect onprognosis of simvastatin in survivors of myocardial infarction - A substudy of the Scandinavian Simvastatin Survival Study, CIRCULATION, 101(12), 2000, pp. 1366-1371

Authors: Paassilta, M Kervinen, K Kesaniemi, YA
Citation: M. Paassilta et al., Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal, ALC CLIN EX, 23(3), 1999, pp. 471-475

Authors: Korhonen, T Hannuksela, ML Seppanen, S Kervinen, K Kesaniemi, YA Savolainen, MJ
Citation: T. Korhonen et al., The effect of the apolipoprotein E phenotype on cholesteryl ester transferprotein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment, EUR J CL PH, 54(12), 1999, pp. 903-910

Authors: Niemi, M Kervinen, K Rantala, A Kauma, H Paivansalo, M Savolainen, MJ Lilja, M Kesaniemi, YA
Citation: M. Niemi et al., The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects, GUT, 44(4), 1999, pp. 557-562

Authors: Kuusisto, J Koivisto, K Mykkanen, L Helkala, E Vanhanen, M Hanninen, T Kervinen, K Kesaniemi, YA Riekkinen, P Laakso, M
Citation: J. Kuusisto et al., Insulin resistance syndrome and Alzheimer's disease: The summary of Finnish studies, RESEARCH AND PRACTICE IN ALZHEIMER'S DISEASE, VOL 2, 1999, pp. 135-139
Risultati: 1-9 |